Ala. AG Loses Bid To Revive $275M AWP Cases
The Alabama Supreme Court has refused to reconsider its reversal of two jury decisions that had awarded the state nearly $275 million from Novartis Pharmaceuticals Corp., GlaxoSmithKline and AstraZeneca LP, putting...To view the full article, register now.
Already a subscriber? Click here to view full article